bharatbook

This report is an essential source for data, analysis and strategic insight into Accuray Incorporated. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company’s business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company’s strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope:-

Revenues for the markets and sub-sectors Accuray Incorporated operates in by country and region.
Detailed breakdowns of revenues and market share benchmarked against competitors.
Profiles of the pipeline of products that the company is developing.
Critical analysis of the company’s strengths, weaknesses opportunities and threats and positioning on the value chain. 
Provides summary analysis of key revenue lines and strategy.
Details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy:-

 A single source to fulfill all of your business and competitor intelligence needs
 Research your competitors business structure, strategy and prospects.
 Counter your competitors strengths and target their weaknesses.
 Identify your competitors key revenue streams by market and geography.
 Identify and assess potential corporate and investment opportunities
 Support sales activities by understanding your customers businesses better.
 Identify potential competitor products before they reach market.
 Qualify prospective partners and suppliers.

For more information,kindly visit - http://www.bharatbook.com/detail.asp?id=82988

Posted in Health

Chiral technology, the process of synthesizing or isolating chiral molecules and their single enantiomers, has become big business for a legion of catalyst developers and custom chemical manufacturers. A few of new drugs are single enantiomers, meaning two mirror-image isomers. Enantiomers are the molecules with pair of mirror image isomers. As drugs, single enantiomers often exhibit greater potency and cause fewer side effects than do more conventional drug molecules, which may be chiral but are often equal-parts mixtures of both enantiomers.

Global revenues from chiral technology will soar from $6.63 billion in 2000 to $16.03 billion in 2007, growing at a compound annual rate of 13.4% during that period.

Approximately 80% of all products currently in development for the pharmaceutical industry are based on chiral building blocks, according to Karlheinz Drauz, vice president for technology and R&D management in the fine chemicals business unit of Degussa AG in Hanau-Wolfgang, Germany. Many single-enantiomer chiral drugs have recently hit the market. Among the more successful ones are AstraZeneca's stomach acid remedy Nexium, GlaxoSmithKline's anti-anxiety agent Paxil, and Merck's asthma drug Singulair.

Bharatbook.com included a new report “Understanding Chiral Technologies” which analyzes the technology involved in the chiral processes, cost of the technology, worldwide sales, the different chiral models, major players in the industry, and the basics of the chiral industry. Market overview, market statistics, information for end-users, and much more is included in this report.

About Bharatbook.com:

Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.

For further information kindly visit: http://www.bharatbook.com/detail.asp?id=79481

Posted in Health